DILG sees no violation in vaccination of Muhlach family in Muntinlupa City | Inquirer News

DILG sees no violation in vaccination of Muhlach family in Muntinlupa City

/ 10:24 AM June 04, 2021

MANILA, Philippines — The Department of the Interior and Local Government (DILG) sees nothing wrong with the COVID-19 vaccination of actor Aga Muhlach, his wife Charlene Gonzales, and their two children since they registered for inoculation as persons with comorbidities.

In a statement on Friday, DILG Undersecretary and spokesperson Jonathan Malaya said that the Muntinlupa City local government unit told the department that the Mulach family are qualified to be vaccinated under the protocols set by the Department of Health.

Article continues after this advertisement

“They are bona-fide residents of Muntinlupa City. They enrolled at the MUNCOVAC registration portal under A3 category,” Malaya said.

FEATURED STORIES

“Most importantly, they submitted medical certificates/clearance from their attending physician at Asian Hospital and Medical Center to prove that they have comorbidities. The medical certificate was verified by the Muntinlupa City Health Office with the said hospital,” he added.

Malaya said documents regarding their vaccination were also submitted to the DILG.

“Therefore, the Department sees no violation of DOH or IATF’s (Inter-Agency Task Force for the Management of Emerging Infectious Diseases) regulations in the aforementioned vaccination,” Malaya added.

gsg
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Aga Muhlach, COVID-19 Vaccine

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.